Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ljubomir Buturovic
Prediction of Overall Survival for Patients With Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge With Open Clinical Trial Data
The Lancet Oncology
Oncology
No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Canadian Urological Association Journal
Urology
Predictive Factors of Response and Overall Survival in Patients With Castration-Resistant Metastatic Prostate Cancer Undergoing177Lu-Psma Therapy
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology
Urology
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer
JAMA Oncology
Cancer Research
Oncology
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Treatment Sequences, Patient Characteristics, and Overall Survival of Patients With Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer in the Community Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer
Cancer
Cancer Research
Oncology
Phase 1 Trial of High-Dose Exogenous Testosterone in Patients With Castration-Resistant Metastatic Prostate Cancer
European Urology
Urology
Analysis of Overall Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Vaccine, Nilutamide, and Combination Therapy
Clinical Cancer Research
Cancer Research
Oncology
